European Network to Cure ALS (ENCALS), Ljubljana 2017
Amyotrophic lateral sclerosis (ALS) is a devastating disease that is still lacking an effective cure. In recent year, research advances offer hope that ALS will eventually become a preventable and treatable disease. Patients, researchers and clinicians worldwide have joined forces in various international projects to make progress towards this goal. European Network to Cure ALS (ENCALS) is a network of ALS centres in Europe that supports such collaborations. 2017 is an exciting year for the ALS community since positive clinical drug trials are promising new treatments after more than two decades.
The ENCALS Meeting 2017 was hosted by the Ljubljana ALS Centre and the Slovenian Society of Clinical Neurophysiology. In three days, a series of plenary lectures, thematic sessions and poster resentations brought together international researchers and clinicians to discuss the advances in research and clinical care.
Masitinib as an add-on therapy to riluzole is beneficial in the treatment of amyotrophic lateral sclerosis (ALS) with acceptable tolerability: Results from a randomized controlled phase 3 trialMasitinib as an add-on therapy to riluzole is beneficial in ...2 comments
[syn] 3004 views, 34:26 Thierry Latran Foundation Lecture
ENCALS Young Investigator Award 2017
Session 1: Therapy
Session 2: Clinical & Epidemiology
AB Science Satellite Meeting
Session 3: Genetics A
Session 4: Genetics B
Session 5: Cognition & Imaging
Session 6: Disease mechanisms A
Session 7: Disease mechanisms B
Session 8: Disease mechanisms C
Closing of the Meeting